These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33123276)

  • 21. Inhibition of miR-214-3p Aids in Preventing Epithelial Ovarian Cancer Malignancy by Increasing the Expression of LHX6.
    Yang C; Kim HS; Park SJ; Lee EJ; Kim SI; Song G; Lim W
    Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31810245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic polymorphisms in the Fas and FasL genes are associated with epithelial ovarian cancer risk and clinical outcomes.
    Li Y; Hao YL; Kang S; Zhou RM; Wang N; Qi BL
    Gynecol Oncol; 2013 Mar; 128(3):584-9. PubMed ID: 23234803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting the outcome of platinum-based chemotherapies in epithelial ovarian cancer using the 8092C/A polymorphism of ERCC1: a meta-analysis.
    Li Y; Hu P; Cao Y; Wang GY; Wang N; Zhou RM
    Biomarkers; 2014 Mar; 19(2):128-34. PubMed ID: 24499239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific point mutations in key redox enzymes are associated with chemoresistance in epithelial ovarian cancer.
    Fletcher NM; Belotte J; Saed MG; Memaj I; Diamond MP; Morris RT; Saed GM
    Free Radic Biol Med; 2017 Jan; 102():122-132. PubMed ID: 27890641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the Wnt-Regulatory Protein CTNNBIP1 by microRNA-214 Enhances the Stemness and Self-Renewal of Cancer Stem-Like Cells in Lung Adenocarcinomas.
    Qi W; Chen J; Cheng X; Huang J; Xiang T; Li Q; Long H; Zhu B
    Stem Cells; 2015 Dec; 33(12):3423-36. PubMed ID: 26299367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic polymorphisms affecting clinical outcomes in epithelial ovarian cancer patients treated with taxanes and platinum compounds: a Korean population-based study.
    Kim HS; Kim MK; Chung HH; Kim JW; Park NH; Song YS; Kang SB
    Gynecol Oncol; 2009 May; 113(2):264-9. PubMed ID: 19203783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KIAA0101, a target gene of miR-429, enhances migration and chemoresistance of epithelial ovarian cancer cells.
    Chen H; Xia B; Liu T; Lin M; Lou G
    Cancer Cell Int; 2016; 16():74. PubMed ID: 27708548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can 9q34.2 rs633862 polymorphism predict survival in epithelial ovarian cancer?
    Jiang R; Xu Y; Wang P; Cheng X; Shi T; Zang R
    PeerJ; 2017; 5():e3946. PubMed ID: 29109911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic polymorphisms in
    Si W; Kang S; Sun H; Chen J; Cao S; Li Y
    Int J Gynecol Cancer; 2019 Sep; 29(7):1148-1155. PubMed ID: 31273068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-520g promotes epithelial ovarian cancer progression and chemoresistance via DAPK2 repression.
    Zhang J; Liu L; Sun Y; Xiang J; Zhou D; Wang L; Xu H; Yang X; Du N; Zhang M; Yan Q; Xi X
    Oncotarget; 2016 May; 7(18):26516-34. PubMed ID: 27049921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair.
    Xiao M; Cai J; Cai L; Jia J; Xie L; Zhu Y; Huang B; Jin D; Wang Z
    J Ovarian Res; 2017 Apr; 10(1):24. PubMed ID: 28376831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Association between single nucleotide polymorphism of BARD1 gene and BRCA1 gene mutation in epithelial ovarian cancer].
    Liu WL; Zhao JZ; Wang ZZ; Dong B; Hou YY; Wu XX; Guo YJ
    Zhonghua Fu Chan Ke Za Zhi; 2017 Jun; 52(6):403-410. PubMed ID: 28647964
    [No Abstract]   [Full Text] [Related]  

  • 34. Transcription factor FOXP3 gene variants affect epithelial ovarian carcinoma in the Han Chinese population.
    Zhang Y; Xu L; Zhou B; Li Q; You D; Liu C; Song H; Wang Y; Song Y; Su M; Huang X; Yuan M; Lan Z; Wang W
    Int J Clin Exp Pathol; 2018; 11(3):1684-1693. PubMed ID: 31938270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Alteration of CTNNBIP1 in Lung Cancer.
    Chang JM; Tsai AC; Huang WR; Tseng RC
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
    Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
    Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TIMP-1 is Overexpressed and Secreted by Platinum Resistant Epithelial Ovarian Cancer Cells.
    Sonego M; Poletto E; Pivetta E; Nicoloso MS; Pellicani R; Vinciguerra GLR; Citron F; Sorio R; Mongiat M; Baldassarre G
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA repair gene associated with clinical outcome of epithelial ovarian cancer treated with platinum-based chemotherapy.
    Kang S; Sun HY; Zhou RM; Wang N; Hu P; Li Y
    Asian Pac J Cancer Prev; 2013; 14(2):941-6. PubMed ID: 23621265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential biomarker of circulating hsa-miR-1273g-3p level for detection of recurrent epithelial ovarian cancer.
    Günel T; Gumusoglu E; Dogan B; Ertem FB; Hosseini MK; Cevik N; Senol T; Topuz S; Aydinli K
    Arch Gynecol Obstet; 2018 Dec; 298(6):1173-1180. PubMed ID: 30264202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatic copy number alterations predict response to platinum therapy in epithelial ovarian cancer.
    Despierre E; Moisse M; Yesilyurt B; Sehouli J; Braicu I; Mahner S; Castillo-Tong DC; Zeillinger R; Lambrechts S; Leunen K; Amant F; Moerman P; Lambrechts D; Vergote I
    Gynecol Oncol; 2014 Dec; 135(3):415-22. PubMed ID: 25281495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.